In summary, our findings demonstrated that in the SH4 melanoma cell line, overexpression of B4GALNT1 as well as its main products GM2/GD2 promotes AIG and cell migration in vitro and enhances tumor incidence by inducing angiogenesis in vivo. This evidence concerns the gene B4GALNT1 and melanoma.